CORT - Corcept Therapeutics GAAP EPS of $0.24 revenue of $103.4M August, 03 2022 04:11 PM Corcept Therapeutics Incorporated Corcept Therapeutics press release ( NASDAQ: CORT ): Q2 GAAP EPS of $0.24. Revenue of $103.4M (+12.9% Y/Y). For further details see: Corcept Therapeutics GAAP EPS of $0.24, revenue of $103.4M